Qigong For PPSP In Breast Cancer Pain In Breast Cancer Survivors
Qigong Mind-Body Exercise For Persistent Post-Surgical Pain In Breast Cancer Survivors: A Pilot Study
1 other identifier
interventional
21
1 country
1
Brief Summary
Studies have shown that on-going pain following breast surgery is common and may limit the ability to participate in physical activity, cause tiredness, difficulty in daily chores/activities as well as other problems. This study is evaluating whether participating in a 12-week Qigong program (pronounced chee kung), an exercise program that involves gentle movements combined with breathing/relaxation techniques, also known as mind-body exercise, leads to improvement of pain, physical function, and quality of life among breast cancer survivors that have significant pain following surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 1, 2016
CompletedFirst Posted
Study publicly available on registry
July 29, 2016
CompletedStudy Start
First participant enrolled
April 4, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 14, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 3, 2023
CompletedFebruary 8, 2023
February 1, 2023
11 months
June 1, 2016
February 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Rate of completion of QMBE intervention
Complete recruitment of target enrollment of 21 participants within 12 month timeframe.
12 months
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0
Total number of adverse events sustained from participation in QMBE will be collected for each participant through home practice logs for at home QMBE participation and instructors will report any adverse events that occur during QMBE class on attendance logs. Any adverse events observed will be evaluated according to the DFCI/Harvard Cancer Center guidelines. The study will be considered safe if zero adverse events are observed/reported from participation in prescribed QMBE classes and/or at home practice.
6 months
Secondary Outcomes (12)
Changes in Quality of life
6 months
Degree of Pain
6 months
Grip Strength
3 months
Gait & Postural Control
3 months
Pain Catastrophizing
3 months
- +7 more secondary outcomes
Study Arms (1)
Qigong Mind-Body Exercise (QMBE)
EXPERIMENTALAfter the screening procedures confirm that you are eligible to participate in the research study: * Breast cancer survivors with persistent post-surgical pain (PPSP) into a 12-week program of Qigong mind-body exercise (QMBE). * Outcome assessments related to pain, function, and quality of life
Interventions
An exercise program that involves gentle movements combined with breathing/relaxation techniques
Eligibility Criteria
You may qualify if:
- History of Stage 0-III breast cancer;
- Persistent post-surgical pain at least 3 months after completion of surgery, chemotherapy, and/or radiation;
- Completion of a course of physical therapy
You may not qualify if:
- Unstable cardiovascular disease in the last 6 months
- Psychiatric disorders or conditions that would preclude participation in the study intervention (e.g. untreated major depression or psychosis, substance abuse, severe personality disorder);
- Metastatic breast or other cancer;
- Participation in more than 240 minutes of moderate-intensity exercise per week (as determined by Leisure Score Index questionnaire)
- Pregnant or breastfeeding
- Recent history of attending regular QMBE or similar classes (e.g. yoga or tai chi classes), (i.e.20 or more classes in the past 6 months).
- Currently enrolled in a physical therapy course
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dana-Farber Cancer Institutelead
- Brigham and Women's Hospitalcollaborator
- Spaulding Rehabilitation Hospitalcollaborator
Study Sites (1)
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer A Ligibel, MD
Dana-Farber Cancer Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr., M.D.
Study Record Dates
First Submitted
June 1, 2016
First Posted
July 29, 2016
Study Start
April 4, 2017
Primary Completion
March 14, 2018
Study Completion
February 3, 2023
Last Updated
February 8, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share